Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).

MLA

Nishio, Teiji, et al. “Dosimetric Verification in Participating Institutions in a Stereotactic Body Radiotherapy Trial for Stage I Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Trial (JCOG0403).” Physics in Medicine and Biology, vol. 51, no. 21, Nov. 2006, pp. 5409–17. EBSCOhost, https://doi.org/10.1088/0031-9155/51/21/002.

APA

Nishio, T., Kunieda, E., Shirato, H., Ishikura, S., Onishi, H., Tateoka, K., Hiraoka, M., Narita, Y., Ikeda, M., & Goka, T. (2006). Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403). Physics in Medicine and Biology, 51(21), 5409–5417. https://doi.org/10.1088/0031-9155/51/21/002

Chicago

Nishio, Teiji, Etsuo Kunieda, Hiroki Shirato, Satoshi Ishikura, Hiroshi Onishi, Kunihiko Tateoka, Masahiro Hiraoka, Yuichirou Narita, Masataka Ikeda, and Tomonori Goka. 2006. “Dosimetric Verification in Participating Institutions in a Stereotactic Body Radiotherapy Trial for Stage I Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Trial (JCOG0403).” Physics in Medicine and Biology 51 (21): 5409–17. doi:10.1088/0031-9155/51/21/002.